Amgen announced the availability of the Enbrel (etanercept) Mini with AutoTouch, a new delivery system for the administration of etanercept.
The AutoTouch is designed to be used with Enbrel Mini single-dose prefilled 50mg/mL cartridges which include a new formulation of Enbrel. A Phase 3b multicenter trial showed that the new formulation of Enbrel resulted in a significant reduction in injection site pain compared to the current formulation.
The design of the AutoTouch includes an ergonomic handle, a needle that stays hidden during injection, and a sensor that detects placement on the skin. It also includes 3 different injection speeds, a progress bar and a speaker.
Enbrel, a tumor necrosis factor (TNF) blocker, is approved to treat several conditions including rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis and plaque psoriasis.
The Enbrel Mini with AutoTouch was approved by the Food and Drug Administration in September 2017.
For more information visit Enbrel.com.